Epidemiology of Kaposi sarcoma: review and description of the nonepidemic variant

被引:65
作者
Vangipuram, Ramya [1 ,2 ]
Tyring, Stephen K. [1 ,2 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA
[2] Ctr Clin Studies, Houston, TX USA
关键词
HIV-NEGATIVE MEN; RISK-FACTORS; HUMAN-HERPESVIRUS-8; SEROPREVALENCE; INFECTION; SEX; MALIGNANCIES; PATHOGENESIS;
D O I
10.1111/ijd.14080
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Kaposi sarcoma (KS) is a rare angioproliferative tumor whose etiology is associated with human herpesvirus 8 (HHV 8). KS lesions typically involve the skin or mucosal surfaces and are characterized by purplish, red-blue, or brown-black macules, papules, and nodules which are prone to bleeding and ulceration. Definitive diagnosis requires biopsy revealing characteristic angioproliferative features. There are four widely recognized types of KS, which are histologically indistinguishable but differ in epidemiology and prognosis. These include classic, endemic, iatrogenic, and epidemic. KS has been increasingly recognized in a new subgroup of patients: men who have sex with men (MSM) but who are HIV-seronegative human immuodeficiency virus-seronegative and have no identifiable immunodeficiency. This fifth variant of KS, termed nonepidemic KS, resembles classic KS in presentation and prognosis. In this literature review, we report the characteristics of nonepidemic KS based on all published cases and highlight the need for clinicians to recognize this new clinical variant.
引用
收藏
页码:538 / 542
页数:5
相关论文
共 39 条
[1]   CHARACTERIZATION OF A DISTINCT SUBGROUP OF HIGH-RISK PERSONS WITH KAPOSIS-SARCOMA AND GOOD PROGNOSIS WHO PRESENT WITH NORMAL T4 CELL NUMBER AND T4-T8 RATIO AND NEGATIVE HTLV-III/LAV SEROLOGIC TEST-RESULTS [J].
AFRASIABI, R ;
MITSUYASU, RT ;
NISHANIAN, P ;
SCHWARTZ, K ;
FAHEY, JL .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (06) :969-973
[2]   KAPOSIS SARCOMA IN A HOMOSEXUAL - 10 YEARS ON [J].
ARCHER, CB ;
SPITTLE, MF ;
SMITH, NP .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1989, 14 (03) :233-236
[3]   Kaposi Sarcoma-Associated Herpesvirus-Associated Malignancies: Epidemiology, Pathogenesis, and Advances in Treatment [J].
Bhutani, Manisha ;
Polizzotto, Mark N. ;
Uldrick, Thomas S. ;
Yarchoan, Robert .
SEMINARS IN ONCOLOGY, 2015, 42 (02) :223-246
[4]  
Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P305
[5]   Malignancies in South African Children With HIV [J].
Davidson, Alan ;
Wainwright, Rosalinda D. ;
Stones, David K. ;
Kruger, Mariana ;
Hendricks, Marc ;
Geel, Jennifer ;
Poole, Janet ;
Reynders, David ;
Omar, Fareed ;
Mathew, Rema ;
Stefan, D. Cristina .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (02) :111-117
[6]  
De Paoli P, 2016, EUR REV MED PHARMACO, V20, P1288
[7]   Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma Belt" [J].
Dollard, Sheila C. ;
Butler, Lisa M. ;
Jones, Alison M. Graves ;
Mermin, Jonathan H. ;
Chidzonga, Midion ;
Chipato, Tsungai ;
Shiboski, Caroline H. ;
Brander, Christian ;
Mosam, Anisa ;
Kiepiela, Photini ;
Hladik, Wolfgang ;
Martin, Jeffrey N. .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (10) :2395-2401
[8]  
Dukers NHTM, 2000, AM J EPIDEMIOL, V151, P213, DOI 10.1093/oxfordjournals.aje.a010195
[9]   Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission [J].
Engels, Eric A. ;
Atkinson, Jonnae O. ;
Graubard, Barry I. ;
McQuillan, Geraldine M. ;
Gamache, Christine ;
Mbisa, Georgina ;
Cohn, Silvia ;
Whitby, Denise ;
Goedert, James J. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (02) :199-207
[10]  
FAY DE, 1990, AM J GASTROENTEROL, V85, P607